Results 31 to 40 of about 123,621 (353)
Background Thirty-three US states and Washington, D.C., have enacted medical cannabis laws allowing patients with chronic non-cancer pain to use cannabis, when recommended by a physician, to manage their condition.
Emma E. McGinty +5 more
doaj +1 more source
Research within a gynecologic oncology population has lagged behind the uptake in use of medical cannabis for symptom control. This study seeks to evaluate patient experience with prescribed medical cannabis obtained through licensed dispensaries in ...
Emily M. Webster +17 more
doaj +1 more source
Legalized use of cannabis products and the rising interest in their therapeutic benefits have opened up new opportunities for therapy and marketing. However, the marked variability in formulations, administration modes, therapeutic regimens, and inter ...
Yaron Ilan, Yaron Ilan
doaj +1 more source
Background There has been a precipitous decline in authorizations for medical cannabis since non-medical cannabis was legalized in Canada in 2018. This study examines the demographic and health- and medical cannabis-related factors associated with ...
Lynda G. Balneaves +9 more
doaj +1 more source
Cannabis legalization and driving under the influence of cannabis in a national U.S. Sample
The relationship between cannabis legalization and traffic safety remains unclear. Physiological measures of cannabis impairment remain imperfect. This analysis used self-report data to examine the relationship between cannabis legalization and driving ...
Lauren M. Dutra +3 more
doaj +1 more source
New Insights into Cannabis Consumption; Abuses and Possible Therapeutic Effects [PDF]
Cannabis is one of the oldest psychotropic drugs known to humanity. The paper assesses the current knowledge on the cannabis, including the mechanisms of action and the therapeutic potential of cannabinoids.
Baconi, Daniela Luiza +2 more
core +3 more sources
Marijuana use among young people in an era of policy change: what does recent evidence tell us? [PDF]
R25 DA030310 - National Institute on Drug ...
Salas-Wright, Christopher P. +1 more
core +1 more source
A novel transcriptional module involving CsYABBY3 and CsAS1 is identified to regulate cannabinoid biosynthesis and trichome development. These factors mutually activate each other and form a protein complex via a conserved residue, acting synergistically to amplify metabolic flux through a coordinate feed‐forward mechanism.
Xuewen Zhu +18 more
wiley +1 more source
High CBD extract (CBD-X) modulates inflammation and immune cell activity in rheumatoid arthritis
IntroductionRheumatoid arthritis (RA) is a debilitating autoimmune disease affecting approximately 1% of the global population and is associated with significant morbidity and mortality.
Miran Aswad +5 more
doaj +1 more source
With the medical use of cannabis permitted in Canada since 2001, patients seek to use this botanical drug to treat a range of medical conditions. However, many healthcare practitioners express the need for further scientific evidence around the use of ...
Shaina P. Cahill +4 more
doaj +1 more source

